Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer^® Clinical Oncology Applications

Oncologists prescribe sNCT/CPT studies to assess the polyneuropathy of cancer and the neurotoxic side-effects of chemotherapeutic agents to assist in developing and modifying treatment plans/goals. A clinical presentation of sensory impairment which requires an objective evaluation for polyneuropathy with testing generally conducted at the great toe test site and a cephalic test site, bilaterally.  See the web page with related publications cited,  Selected Neurometer® CPT Research Publications Grouped by Topic and Specialty.